Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm

N Song, H Wakimoto, F Rossignoli, D Bhere… - Stem Cells, 2021 - academic.oup.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic has grown to be a global
public health crisis with no safe and effective treatments available yet. Recent findings …

Mesenchymal stem cell therapy for severe COVID-19

L Shi, L Wang, R Xu, C Zhang, Y Xie, K Liu… - Signal transduction and …, 2021 - nature.com
Abstract The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has placed a global public burden on health …

The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm

M Kavianpour, M Saleh, J Verdi - Stem Cell Research & Therapy, 2020 - Springer
The outbreak of coronavirus disease 2019 (COVID-19) pandemic is quickly spreading all
over the world. This virus, which is called SARS-CoV-2, has infected tens of thousands of …

Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID-19

BL Yen, ML Yen, LT Wang, KJ Liu… - Stem cells translational …, 2020 - academic.oup.com
The broad immunomodulatory properties of human mesenchymal stem cells (MSCs) have
allowed for wide application in regenerative medicine as well as immune/inflammatory …

Mesenchymal stem cell immunomodulation and regeneration therapeutics as an ameliorative approach for COVID-19 pandemics

P Yadav, R Vats, A Bano, R Bhardwaj - Life Sciences, 2020 - Elsevier
The severe acute respiratory syndrome-novel coronavirus mediated COVID-19 has been
recently declared a pandemic by the World Health Organization. The primary target of the …

Mesenchymal stem cells as a potential therapy for COVID-19

S Liu, D Peng, H Qiu, K Yang, Z Fu, L Zou - Stem cell research & therapy, 2020 - Springer
The outbreak of 2019 novel coronavirus disease (COVID-19) worldwide is becoming rapidly
a major concern. The number of severe cases has increased dramatically worldwide, while …

[HTML][HTML] Fostering mesenchymal stem cell therapy to halt cytokine storm in COVID-19

M Jeyaraman, A John, S Koshy, R Ranjan… - … et Biophysica Acta (BBA …, 2021 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) has been threatening the globe since
the end of November 2019. The disease revealed cracks in the health care system as health …

Mesenchymal stem cells: a new front emerges in coronavirus disease 2019 treatment

SS Raza, MA Khan - Cytotherapy, 2022 - Elsevier
Currently, treating coronavirus disease 2019 (COVID-19) patients, particularly those afflicted
with severe pneumonia, is challenging, as no effective pharmacotherapy for severe acute …

The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect

A Can, H Coskun - Stem Cells Translational Medicine, 2020 - academic.oup.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-caused coronavirus
disease 2019 (COVID-19) pandemic has become a global health crisis with an extremely …

Insights into the use of mesenchymal stem cells in COVID-19 mediated acute respiratory failure

N Durand, J Mallea, AC Zubair - NPJ Regenerative medicine, 2020 - nature.com
The emergence of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) at the
end of 2019 in Hubei province China, is now the cause of a global pandemic present in over …